Ono Pharmaceutical Co., Ltd.

OPHLY · OTC
Analyze with AI
9/30/2025
6/30/2025
3/31/2025
12/31/2024
Operating Activities
Net Income$153$17,673-$6,545$14,951
Dep. & Amort.$63$9,238$8,728$9,170
Deferred Tax$0$0$0$0
Stock-Based Comp.$0$0$0$0
Change in WC$87-$168$256$24
Other Non-Cash$50-$26,720$36,557-$24,082
Operating Cash Flow$353$3,373$38,996$63
Investing Activities
PP&E Inv.-$12-$2,250-$1,421-$1,204
Net Acquisitions$0$0$0$0
Inv. Purchases-$9$0$0$0
Inv. Sales/Matur.$33$0$0$0
Other Inv. Act.-$2$1,952$16,747$1,237
Investing Cash Flow$10-$298$15,326$33
Financing Activities
Debt Repay.-$51-$8,354-$8,306-$26
Stock Issued$0$0$0$0
Stock Repurch.-$0$0$0-$0
Dividends Paid-$9-$17,396-$992-$17,770
Other Fin. Act.-$6$25,572-$0$17,644
Financing Cash Flow-$66-$178-$9,298-$152
Forex Effect-$26$47-$1,442-$88
Net Chg. in Cash$271-$406$43,585-$144
Supplemental Information
Beg. Cash$962$1,368$160,982$1,168
End Cash$1,233$962$204,567$1,024
Free Cash Flow$341$1,123$37,575$55